In spite of the recent improved results of hepatectomy for huge hepatocellular carcinomas (HCC), the prognosis of patients with huge HCCs is still poor compared to that of patients with small HCCs. This study was performed to compare the results of hepatectomy between patients with huge HCCs and those with small HCCs, to identify the prognostic factors in patients with huge HCCs, and to determine the preoperative selection criteria. Methods: We retrospectively analyzed 51 patients who underwent hepatectomy, between July 1994 and February 2009 at Dankook University Hospital. Patients with HCC≥10 cm were classified in large (L) group and others were classified in small (S) group. The clinicopathological features, operative procedures, and postoperative outcome were compared between both groups and various prognostic factors were investigated in group L. Results: Eleven patients were classified in group L. Tumor size, vascular invasion, and tumor stage were higher in group L. Postoperative morbidity was higher in group L, but mortality was not different between the groups. Disease-free survivals were significantly lower in group L than in group S (36.4%, and 24.2% vs. 72.0%, and 44.0% for 1-and 3-year), but overall survival rates were similar in both groups (45.5%, and 15.2% in group L vs. 60.3%, and 41.3% in group S for 3-and 5-year). Presence of satellite nodules was the only prognostic factor in multivariate analysis after surgery for huge HCC. Conclusion: Regardless of tumor size, huge HCCs deserve consideration for surgery in patients with preserved liver function. Furthermore, the effect of surgery could be maximized with appropriate selection criteria, such as huge HCC without satellite nodules.
Introduction
According to recent publications on cancer incidence in Korea by the Korea Central Cancer Registry, 1 Huge HCC, which is generally defined when its greatest diameter is 10 cm or more, although there is a variation according to literatures, has a poorer prognosis than that of smaller HCC due to higher incidence of vascular invasion and more aggressive tumor biology. Unfortunately, patients with huge HCC are not eligible for other treatment modalities such as liver transplantation, percutaneous ethanol injection therapy (PEIT), radiofrequency ablation (RFA), and while some centers tries transarterial embolization (TAE), the 5-year survival rate is less than 10%.
Consequently, surgical resection remains the only treatment option that offers opportunities for long-term survival or complete cure. However, surgical resection of huge HCCs is a great challenge to the liver surgeons, because surgery for these tumors entails prolonged operative time and has an increased risk for massive bleeding or liver failure after major hepatectomies in patients with chronic hepatitis or early stage cirrhosis; furthermore, rapid recurrence after surgery is not infrequent.
An increasing number of studies have reported favorable outcomes after hepatectomy for huge HCC, [2] [3] [4] [5] [6] [7] but the results of surgical intervention in huge HCCs still remain poor compared to that of small HCCs. To maximize the effect of surgical resection through prolongation of survival duration and improving the quality of life in patients with huge HCC, adequate selection of candidates for surgery is of great importance.
This study was performed to investigate the effect of hepatectomy for huge HCC by comparing the surgical outcomes of patients with huge HCC to those of patients with small HCC, and to establish surgical strategy for preoperative patient selection by identification of independent prognostic factors in patients with huge HCC. Type of hepatectomy was divided into major resection;
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which was the resection of more than 3 segments according to the Couinaud classification of liver anatomy, and minor resection; in which less than 2 segments were removed.
Laparoscopic surgery was not separately classified and was
analyzed together with open surgery in this study. Each of the selected factors was first subjected to univariate analysis in order to determine the statistical significance, and only the significant factors then went through multivariate analysis to identify the final significant independent prognostic factors for overall survival in patients with huge HCC.
Statistical analysis
Statistical analyses were performed by PASW for 
Results
Clinicopathological and histopathological characteristics
During this study period, the number of patients who received partial hepatectomy for HCC was 51, of which 11 (21.6%) patients had tumor size larger than 10 cm (group L). Comparison of the clinicopathological and histopathological characteristics between group L and group S is shown in Table 1 and Table 2 . Among the total 51 patients, the male patients (42, 82.4%) outnumbered the female patients; the male : female ratio in group L was almost equal (6 : 5), while in group S this ratio was significantly shifted towards males (9 : 1, p=0.015). The mean age was similar in the two groups (52.4 years in group L and 54.6 years in group S respectively). The most common cause of chronic liver disease was viral hepatitis B in both groups.
All patients in group L were in Child-Pugh class A, while a small proportion (12.5%) of patients in group S were in Child-Pugh class B. The pushing type HCC was found to be the most common gross type (63.6% in group L, 62.5% in group S), and there was no difference in the distribution of gross classification between both groups. Curative resection was achieved in all group L patients, which was similar in group S patients (90% were significantly higher in group L, no significant diffe- .000
UICC=the international union against cancer rence between the two groups was found in terms of tumor cell differentiation, satellite nodules, capsular invasion, ruptured tumor, and resection margin. The incidence of liver cirrhosis showed significant difference between group L (36.4%) and group S (92.5%), which explains the higher proportion of Child-Pugh A patients in group L.
Outcomes related to surgery and postoperative complications
Proportion of major hepatectomy, operative time, intraoperative blood loss, postoperative hospital stay, and morbidity rate were significantly higher in group L, however perioperative transfusion and mortality rate were similar in both groups (Table 3 ). All patients in group L underwent major hepatectomy, among which 2 cases of right hemihepatectomy with partial resection of diaphragm were included. In contrast, major hepatectomy was performed in only 25% of patients in group S, thereby showing a marked difference between the two groups.
Perioperative transfusion rates were relatively high in both groups. Morbidity rate was two-fold higher in group L compared to group S. Major complications comprised bile leakage, intraabdominal bleeding and abscess, pleural effusion, liver abscess, wound dehiscence, and minor complications were wound seroma, ascites, minor bile leakage, and mild pleural effusion. There was one death due to liver failure in group L, and two deaths due to intraabdominal bleeding in group S. 
Postoperative recurrence and survival analysis
The median follow-up duration for survival analysis was 30 months. During this period, postoperative recurrence was detected in 8 patients (72.7%) in group L and 17 patients (42.5%) in group S. The 1-and 3-year disease-free survival rates in group L were 36.4% and 24.2%s, respectively, which were significantly lower than those in group S (72.0% and 44.0%, respectively, p=0.030, Fig. 1 ). In addition, the median disease-free survival was significantly lower in group L (4.0 months) compared to 31.0 months in group S (p=0.030). In contrast, the 1-year, 3-year, and 5-year survival rates in group L (45.5%, 45.5%, and 15.2%, respectively) were lower than those in group S (80.0%, 60.3%, and 41.3%, respectively), but this difference was not statistically significant (Fig. 2) .
Prognostic factors for overall survival in patients with huge HCC
Univariate analysis revealed presence of satellite nodules was the only independent factor affecting overall survival of group L (Table 4) . In multivariate analysis, where the potential prognostic factors of p-value less than 0.1 in univariate analysis, such as age, AFP level, microscopic vascular invasion, and tumor TNM stage were analyzed together with satellite nodules, the only significant prognostic factor was again satellite nodules. The 1-year survival rate in patients with huge HCC accompanied with satellite nodules was 0%, while patients without satellite nodules showed the survival rate was 83.3% at 1 and 3 years.
Discussion
In general, the prognosis of HCC has been known to become poorer as the tumor size increases due to progression of vascular invasion and aggravation of tumor biology.
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In the present study, macroscopic and microscopic vascular invasion were more frequent in group L, but tumor cell differentiation showed no significant difference between the two groups. In addition, although numerical values of survival rates of both group were different, these difference had no statistical significance.
Furthermore, it is not uncommon to find literature that reports no difference in survival between patients with huge HCC and small HCC. 6, 7, 12 In a series of Shah et al., 7 the 5-year overall survival rate for patients with huge HCC has been reported to be as high as 54%, while the majority of researchers, who conducted the study under similar conditions, have reported the survival rate to be 20∼40%. [4] [5] [6] 11, [13] [14] [15] [16] [17] [18] [19] [20] The reported 5-year survival rates continue to remain high, especially in the recent studies. In contrast, the 5-year survival for patients with huge HCC in this study was a slightly lower (15.2%), and this is thought to be attributable to the inclusion of patients who underwent surgery a long time ago, and the small number of patients enrolled in the study. Pandey et al. 16 reported a 5-year survival rate of 28.6% after surgery for huge HCC, which increased to 57.7% in the absence of significant independent factors for survival such as vascular invasion, liver cirrhosis, and satellite nodules, and decreased to 22.5% when at least 1 independent factor was present. Similarly, Shimada et al. 21 reported that in patients with a single nodular huge HCC without gross tumor thrombus, the postoperative 5-year survival rate was 69.8%, thereby demonstrating high survival rates in selected patients with huge HCC. As in a similar study by Taniai et al., 17 those patients who had liver cirrhosis with gross vascular invasion or with multiple nodular huge HCC were excluded from the selected group for surgery. These suggest that in order to improve postoperative survival, a meticulous selection of patients for surgery is requisite.
As seen to date from the results of numerous studies, 2, 7, 13, 17, 18 the present study showed that early recurrence rate within the first year after surgery and the overall recurrence rate were significantly high in patients with huge HCC. Early recurrence within the first year after surgery occurred in 7 (63.6%) patients in group L, and this rate was significantly higher than that of patients (10, 25 .0%) in group S. This high recurrence rate of huge HCCs is probably not only due to the biologic characteristics of easy recurrence, but also to a certain extent, due to tumor cell dissemination that results from manipulation of tumor or mobilization of the liver containing tumor during operation. Accordingly, in order to minimize such tumor cell dissemination during operation for huge HCCs, the employment of the anterior approach or the liver hanging maneuver has increased in recent years. [22] [23] [24] [25] [26] [27] Among the 10 patients in group L, 3 were alive at the time of this study. Two of these surviving patients had Taniai et al. 17 and Pawlik et al. 11 concluded that the presence of liver cirrhosis in patients with huge HCCs was a significant prognostic factor, and Taniai et al. 17 further postulated that huge HCCs with gross vascular invasion or multiple tumors in cirrhotic background were not appropriate for surgery. Since liver cirrhosis itself is a risk factor for recurrence of HCC in the remnant liver, it is an independent prognostic factor for survival, irrespective of tumor size. In this study, despite the fact that liver cirrhosis was present in 4 (36.4%) patients with huge HCCs, there was no significant difference in survival according to liver cirrhosis. This may be due to mild cirrhosis with relatively preserved liver function of Child-Pugh classification A.
Another possible reason is that survival was determined by other more significant factors related to tumor, rather than cirrhosis.
It is the common expectation of all liver surgeons to maximize the surgical outcomes by appropriate selection of patients with huge HCCs for surgery, based upon studies of independent prognostic factors for survival. In this context, Poon et al. 2 and Shimada et al. 21 
Conclusion
Although the number of cases was small and further studies are required in future, considering the results of this study that there was no significant statistical difference in overall survival after surgery in both groups, as the similar results of the previous studies on surgical treatment for huge HCC, surgical resection for huge HCCs should be actively attempted, irrespective of tumor size, as long as the patient's condition is acceptable. Furthermore, to enhance surgical outcome of huge HCC and to improve quality of life in these patients, careful and appropriate selection of candidates for surgery should be based on the independent prognostic factors, such as satellite nodules.
